Next 10 |
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 20.3% to $0.0699 on volume of 164,902,840 shares Safe and Green Development Corporation (SGD) rose 36.7% to $0.8477 on volume of 100,466,382 shares PROSHARES TRUST (SQQQ) fell 0.6% to $1...
2024-05-09 13:12:57 ET More on mid-day movers & stocks. SkyWater Earnings Preview: Products In High Demand CareCloud, Inc. (CCLD) Q4 2023 Earnings Call Transcript SkyWater Technology, Inc. 2023 Q4 - Results - Earnings Call Presentation SkyWater Technology...
2024-05-09 11:33:48 ET More on Amgen, CytomX, etc. CytomX Therapeutics, Inc. (CTMX) Q1 2024 Earnings Call Transcript Amgen Could Become A Real Contender In The Obesity Market Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending Cy...
2024-05-09 10:00:35 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 22.2% to $0.071 on volume of 95,914,661 shares Pop Culture Group Co. Ltd (CPOP) rose 128.8% to $3.89 on volume of 39,763,492 shares Safe and Green Development Corporation (SGD) rose 40.7...
2024-05-08 21:22:10 ET CytomX Therapeutics, Inc. (CTMX) Q1 2024 Results Conference Call May 08, 2024 05:00 PM ET Company Participants Chris Ogden - Senior Vice President, Finance and Accounting Sean McCarthy - Chief Executive Officer and Chairman Wayne Chu - Chie...
2024-05-08 17:38:27 ET Gainers: CytomX Therapeutics ( CTMX ) +77% . Tarsus Pharmaceuticals ( TARS ) +15% . ZimVie ( ZIMV ) +13% . Equinix ( EQIX ) +11% . Consensus Cloud Solutions ( CCSI ) +10% . Losers: Cardl...
2024-05-08 16:34:08 ET More on CytomX CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town CytomX Therapeutics, Inc. (CTMX) Q4 2023 Earnings Call Transcript Cyt...
- Company announces positive initial Phase 1a dose escalation data for monotherapy CX-904 (EGFRxCD3 T-cell engager) in solid tumors - - First dose cohort cleared in Phase 1 clinical study of CX-2051, an EpCAM Targeting PROBODY ® ADC, in solid tumors. Initial data anticipated in...
- CX-904 demonstrated a favorable safety profile with no cytokine release syndrome (CRS) of any grade observed in step-dosing cohorts and no grade >1 CRS observed overall - - Encouraging initial signs of efficacy observed for CX-904 in advanced pancreatic cancer, including 2 of 6 pat...
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
Wednesday, CytomX Therapeutics Inc (NASDAQ:CTMX) released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, d...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping over 200 points on Thursday. The Dow traded up 0.63% to 39,30...
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results. Duol...